XML 82 R68.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]      
Net operating loss carryforwards $ 3,078,000 $ 2,320,000  
R&D credit 2,443,000 1,424,000  
Capitalized R&D expenses 5,617,000 2,647,000  
Capitalized start-up expenses 15,628,000 4,652,000  
Operating lease liabilities 216,000 0  
Stock-based compensation 394,000 80,000  
Depreciation and amortization 73,000 17,000  
Accrued expenses 0 44,000  
Deferred tax assets 27,449,000 11,184,000  
Valuation allowance (26,775,000) (11,184,000) $ (6,777,000)
Total deferred tax assets 674,000 0  
Right-of-use assets (207,000) 0  
Unrealized gain on marketable securities (467,000) 0  
Total deferred tax liabilities (674,000) 0  
Net deferred assets $ 0 $ 0